CRTh2 antagonist 2
CAS No. 780763-95-3
CRTh2 antagonist 2( —— )
Catalog No. M32868 CAS No. 780763-95-3
CRTh2 antagonist 2 is a selective and potent CRTH2 antagonist, IC50≤10 nM. CRTh2 antagonist 2 can be used to study the direction of androgenic alopecia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 166 | Get Quote |
|
| 5MG | 205 | Get Quote |
|
| 10MG | 334 | Get Quote |
|
| 25MG | 517 | Get Quote |
|
| 50MG | 707 | Get Quote |
|
| 100MG | 888 | Get Quote |
|
| 500MG | 1782 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCRTh2 antagonist 2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCRTh2 antagonist 2 is a selective and potent CRTH2 antagonist, IC50≤10 nM. CRTh2 antagonist 2 can be used to study the direction of androgenic alopecia.
-
DescriptionCRTh2 antagonist 2 is selective and potent CRTH2 antagonist extracted from patent US20140148470A1, compound Example 1, has an IC50 of ≤10 nM. CRTh2 antagonist 2 can be used in research of androgenic alopecia.
-
In VitroCRTH2 (chemoattractant receptor-homologous molecule expressed on Th2 cells) protein, also known as GPR44, is a G-protein coupled receptor (GPCR) which is amongst other ligands most strongly activated by prostaglandin D2 (PGD2). PGD2 is a product of prostaglandin D2 synthase (PTGDS).
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorGPR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number780763-95-3
-
Formula Weight474.94
-
Molecular FormulaC26H23ClN4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (263.19 mM; Ultrasonic )
-
SMILESCN(C)c1nc(Cc2ccc(NC(=O)c3ccc4ccccc4c3)cc2)nc(Cl)c1CC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Andreas Schnapp, et al. Pyrimidine compounds for treating hairloss. US20140148470A1.
molnova catalog
related products
-
FL104
FL104 is a potent agonist of small-molecule urotensin II receptor, pEC50= 7.11.
-
GSK256073
GSK256073 is an orally active GPR109A agonist. GSK256073 also is a long-lasting and non-flushing HCA2 (hydroxy-carboxylic acid receptor 2) full agonist.
-
MBX2982
MBX-2982 is a selective, orally-available GPR119 agonist for the treatment of type 2 tiabetes.
Cart
sales@molnova.com